Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 129-131

  Gordon, Nicola C ^a   Wareham, David W ^a,b  

^a Division of Infection and Immunity   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

EGCG; Stenotrophomonas maltophilia

Indexed keywords

EPIGALLOCATECHIN GALLATE; POLYPHENOL;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; COLONY FORMATION; COLORIMETRY; CONCENTRATION (PARAMETERS); MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; TEA;

ANTI-BACTERIAL AGENTS; CAMELLIA SINENSIS; CATECHIN; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; STENOTROPHOMONAS MALTOPHILIA;

EID: 77953810434     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.025     Document Type: Article

References (23)

1. Denton M., Kerr K. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998, 11:57-80.
2. Rogues A.M., Maugein J., Allery A., Fleureau C., Boulestreau H., Surcin S., et al. Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia. J Hosp Infect 2001, 49:289-292.
3. Weber D.J., Rutala W.A., Blanchet C.N., Jordan M., Gergen M.F. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control 1999, 27:59-63.
4. Verweij P.E., Meis J.F., Christmann V., Van der Bor M., Melchers W.J., Hilderink B.G., et al. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect 1998, 120:251-256.
5. Crossman L.C., Gould V.C., Dow J.M., Vernikos G.S., Okazaki A., Sebaihia M., et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 2008, 17:R74.
6. Toleman M.A., Bennett P.M., Bennett D.M., Jones R.N., Walsh T.R. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007, 13:559-565.
7. Nicodemo A.C., Garcia Paez J.I. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007, 26:229-237.
8. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., et al. Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA 2006, 296:1255-1265.
9. Yoda Y., Hu Z.Q., Zhao W.H., Shimamura T. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother 2004, 10:55-58.
10. Osterburg A., Gardner J., Hyon S.H., Neely A., Babcock G. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG). Clin Microbiol Infect 2009, 15:341-346.
11. Andrews J.M. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009, 64:454-489. BSAC Working Party on Susceptibility Testing.
12. Moriarty F., Elborn S., Tunney M. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa. J Microbiol Methods 2005, 61:171-179.
13. Anand P.K., Kaul D., Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int J Biochem Cell Biol 2006, 38:600-609.
14. Park B.J., Park J.C., Taguchi H., Fukushima K., Hyon S.H., Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun 2006, 347:401-405.
15. Ikigai H., Nakae T., Hara Y., Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1993, 1147:132-136.
16. Gradisar H., Pristovsek P., Plaper A., Jerala R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem 2007, 50:264-271.
17. Navarro-Martínez M.D., Navarro-Perán E., Cabezas-Herrera J., Ruiz-Gómez J., García-Cánovas F., Rodríguez-López J.N. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2005, 49:2914-2920.
18. Unno T., Kondo K., Itakura H., Takeo T. Analysis of (-)-epigallocatechin in human serum obtained after ingesting green tea. Biosci Biotechnol Biochem 1996, 60:2066-2068.
19. Javaid A., Bonkovsky H.L. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 2006, 45:334-335.
20. Camouse M.M., Domingo D.S., Swain F.R., Conrad E.P., Matsui M.S., Maes D., et al. Topical application of green and white tea extract provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol 2009, 18:522-526.
21. Kim H., Kawazoe T., Han D.W., Matsumara K., Tsutsumi S., Hyon S.H. Enhanced wound healing by an epigallocatechin-incorporated collagen sponge in diabetic mice. Wound Repair Regen 2008, 16:714-720.
22. Zhao W.H., Asano N., Hu Z.Q., Shimamura T. Restoration of antibacterial activity of β-lactams by epigallocatechin gallate against β-lactamase-producing species depending on location of β-lactamase. J Pharm Pharmacol 2003, 55:735-740.
23. Bernal P., Zloh M., Taylor P.W. Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (-)-epicatechin gallate. J Antimicrob Chemother 2009, 63:1156-1162.